Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
ADC Therapeutics
ADC Therapeutics
(ADCT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zynlonta
Loncastuximab tesirine
2021-04-23
Large b-cell lymphoma diffuse
,
B-cell lymphoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loncastuximab tesirine
leukemia
,
lymphoid leukemia
,
b-cell chronic lymphocytic leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
burkitt lymphoma
,
central nervous system neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
hodgkin disease
Epratuzumab
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
philadelphia chromosome
,
lymphoid leukemia
Edrecolomab
breast neoplasms
Calcium dobesilate
leukemia
,
hematologic neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
Lornoxicam
prostatic neoplasms
,
plasmablastic lymphoma
,
large-cell lymphoma immunoblastic
,
renal insufficiency
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
smoldering multiple myeloma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
paraproteinemias
,
monoclonal gammopathy of undetermined significance
,
multiple myeloma
,
plasma cell neoplasms
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
amyloidosis
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
Bevifimod
ovarian neoplasms
,
fallopian tube neoplasms
,
peritoneal neoplasms
CAMIDANLUMAB
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
urinary bladder neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
lymphoma
,
hodgkin disease
,
myelodysplastic syndromes
,
neoplasms
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
preleukemia
CAMIDANLUMAB TESIRINE
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
breast neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
lymphoma
,
hodgkin disease
,
myelodysplastic syndromes
,
neoplasms
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
preleukemia
Loncastuximab
leukemia
,
lymphoid leukemia
,
b-cell chronic lymphocytic leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
burkitt lymphoma
,
central nervous system neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
hodgkin disease
Nepidermin
healthy volunteers/patients
,
pancreatic neoplasms
,
glioma
,
skin neoplasms
,
pharyngeal neoplasms
,
fallopian tube neoplasms
,
neoplasms
,
melanoma
,
head and neck neoplasms
,
colorectal neoplasms
,
brain neoplasms
,
rectal neoplasms
,
renal cell carcinoma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
squamous cell carcinoma
,
disease progression
,
retinal diseases
,
diabetic retinopathy
,
glioblastoma
,
gliosarcoma
,
kidney neoplasms
,
squamous cell carcinoma of head and neck
,
systemic scleroderma
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
sarcoma
,
hemangiosarcoma
,
breast neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
lymphoma
,
macular edema
,
edema
,
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
,
chronic urticaria
,
urticaria
,
ovarian neoplasms
,
non-hodgkin lymphoma
,
diabetes mellitus
,
retinal vein occlusion
,
central venous catheters
,
triple negative breast neoplasms
,
stomach neoplasms
,
hemorrhage
,
cerebral hemorrhage
,
adenocarcinoma
,
neoplasm metastasis
,
rheumatoid arthritis
,
arthritis
,
macular degeneration
,
wet macular degeneration
,
follicular lymphoma
,
thrombosis
,
hemophilia a
,
cerebral intraventricular hemorrhage
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
asthma
Odronextamab
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
b-cell lymphoma
Palifosfamide
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
b-cell lymphoma
Microcrystalline cellulose
zika virus infection
,
zika virus
,
lyme disease
,
borrelia infections
,
ventilator-associated pneumonia
,
clostridium infections
,
clostridioides difficile
,
virus diseases
,
chikungunya fever
,
encephalitis
,
japanese encephalitis
,
pseudomonas infections
,
chikungunya virus
Caelyx
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
Doxorubin
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use